Implementation and evaluation of aCYP2C19genotypeguided antiplatelet therapy algorithm in high-risk coronary artery disease patients.

171.

  • Lee, John Andrew Pharm.D.
  • Reed, Brent N. Pharm.D., BCPS
  • Plitt, David C. M.D.
  • Cicci, Jonathan D. Pharm.D., BCPS
  • Tasca, Kristen E. Pharm.D.
  • Weck, Karen E. M.D.
  • Lee, Craig R. Pharm.D., Ph.D., FCCP
  • Stouffer, George A. M.D.

  • (1)UNC Eshelman School of Pharmacy, Chapel Hill, NC; (2)University of Maryland School of Pharmacy, Baltimore, MD; (3)School of Medicine; University of North Carolina Hospitals and Clinics, Chapel Hill, NC; (4)University of North Carolina Hospitals and Clinics, Chapel Hill, NC; (5)School of Medicine, University of North Carolina, Chapel Hill, NC; (6)Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC; (7)Division of Cardiology, UNC School of Medicine, Chapel Hill, NC

Pharmacotherapy: The Journal Of Human Pharmacology & Drug Therapy 34(10):p e221, October 2014.
Copyright © Pharmacotheraphy Publications, Inc. All rights reserved.